The effects of economic status on metabolic control in type 2 diabetes mellitus at 10 metabolic management centers in China

Author:

Gu Liping1ORCID,Ma Yuhang1,Zheng Qidong2,Gu Weiqiong34ORCID,Ke Tingyu5,Li Li6,Zhao Dong7ORCID,Dai Yuancheng8,Dong Qijuan9,Ji Bangqun10,Xu Fengmei11,Shi Juan34ORCID,Peng Ying34ORCID,Zhang Yifei34ORCID,Shen Tingting1,Du Rui1,Yang Jiaying1,Kang Mei12,Peng Yongde1,Wang Yufan1,Wang Weiqing34

Affiliation:

1. Department of Endocrinology and Metabolism, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

2. Department of Internal medicine The Second People's Hospital of Yuhuan Yuhuan China

3. Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

4. Shanghai National Clinical Research Center for metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

5. Department of Endocrinology The Second Affiliated Hospital of Kunming Medical University Kunming China

6. Department of Endocrinology The First Affiliated Hospital of Ningbo University Ningbo China

7. Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital Capital Medical University Beijing China

8. Department of Internal medicine of traditional Chinese medicine Sheyang Diabetes Hospital Yancheng China

9. Department of Endocrinology and Metabolism People's Hospital of Zhengzhou Affiliated Henan University of Chinese Medicine Zhengzhou China

10. Department of Endocrinology Xingyi People's Hospital Xingyi China

11. Department of Endocrinology and Metabolism, Hebi Coal (group). LTD General hospital Hebi China

12. Clinical Research Center, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

Abstract

AbstractObjectiveThis study investigated the association of economic status with metabolic index control in type 2 diabetes mellitus (T2DM) patients.MethodsIn total, 37 454 T2DM patients from 10 National Metabolic Management Centers in China were recruited and categorized into two groups: a high‐gross domestic product (GDP) group (n = 23 993) and a low‐GDP group (n = 13 461). Sociodemographic characteristics, medical histories, and lifestyle factors were recorded. Logistic regression and interaction analysis were performed to evaluate the association of economic status and healthy lifestyle with metabolic control.ResultsCompared to the low‐GDP group, there were fewer patients with glycated hemoglobin (HbA1c) levels ≥7% in the high‐GDP group. Fewer patients with a high GDP had an abnormal metabolic state (HbA1c ≥ 7%, blood pressure [BP] ≥130/80 mm Hg, total cholesterol [TCH] ≥4.5 mmol/L or body mass index [BMI] ≥24 kg/m2). The risks of developing HbA1c ≥ 7% (odds ratios [OR] = 0.545 [95% CI: 0.515–0.577], p < .001), BP ≥ 130/80 mm Hg (OR = 0.808 [95% CI: 0.770–0.849], p < .001), BMI ≥ 24 kg/m2 (OR = 0.840 [95% CI: 0.799–0.884], p < .001), and an abnormal metabolic state (OR = 0.533 [95% CI: 0.444–0.636], p < .001) were significantly lower in the high‐GDP group even after adjustment for confounding factors. Younger participants; those with a family history of diabetes, normal weight, and a physical activity level up to standard; and those who did not drink alcohol in the high‐GDP group were predisposed to better glycemic levels.ConclusionsT2DM patients in economically developed regions had better metabolic control, especially glycemic control. A healthy lifestyle had an additive effect on achieving glycemic goals, even among high‐GDP patients.

Funder

China International Medical Foundation

National Natural Science Foundation of China

Shanghai Shenkang Hospital Development Center

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3